Furthermore, Filippatos et al. [25] and Tóth et al. [26] reported significantly higher PCSK9 levels in obese individuals compared with normal-weight controls, supporting the concept that PCSK9 may act as a metabolic biomarker linking excess adiposity with lipid dysregulation and increased cardiovascular disease risk. The gene discussed is PCSK9; the disease is cardiovascular disorder.